Dexmedetomidine Found to Prevent Delirium in Critically Ill

Share this content:
Dexmedetomidine Found to Prevent Delirium in Critically Ill
Dexmedetomidine Found to Prevent Delirium in Critically Ill

MONDAY, March 5, 2018 (HealthDay News) -- Low-dose dexmedetomidine significantly reduces delirium in critically ill adults, according to a study published online March 2 in the American Journal of Respiratory and Critical Care Medicine.

Yoanna Skrobik, M.D., from McGill University in Montreal, and colleagues randomized 100 delirium-free, critically ill adults receiving sedatives to receive nocturnal intravenous dexmedetomidine (0.2 mcg/kg/min) or placebo until discharge from the intensive care unit (ICU). Effect on delirium and sleep was assessed.

The researchers found that nocturnal dexmedetomidine was associated with a greater proportion of patients who remained delirium-free during the ICU stay (relative risk, 0.44; P = 0.006). However, the average Leeds Sleep Evaluation Questionnaire score was similar between the two groups. The groups also had similar incidence of hypotension, bradycardia, or both.

"To our knowledge, this study, that suggests that the nocturnal administration of low-dose dexmedetomidine significantly reduces delirium without increasing adverse events, is the first to describe an effective pharmacologic delirium prevention intervention in critically ill adults," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »